2010 Workshop on Immunotherapy Combinations Schedule

Workshop Main Page  |  Highlights  |  Program Purpose  |  Presentations Slides & Schedule | Faculty
Preliminary Program  |  Photos

October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.

Program Schedule
To view slides from a presenter click the icon next to the presentation title.

Friday, October 1, 2010
8:00 am - 8:15 am	Welcome & Overview: Monoclonal Antibodies in Cancer George J. Weiner, MD - University of Iowa
8:15 am - 10:05 am	Session 1: Tumor-Targeted Antibodies Chair:  Ira Mellman, PhD - Genentech, Inc. Targeting Activated HER2 in Solid Tumors Mark X. Sliwkowski, PhD - Genentech, Inc.  Monoclonal Antibody Immunotherapy Louis M. Weiner, MD - Georgetown University Medical Center Combining Tumor-Reactive mAbs with Cytokines to Induce ADCC in Patients Paul M. Sondel, MD, PhD - University of Wisconsin, Madison
10:30 am - 12:00 pm	Session 2: Immunomodulatory Antibodies Chair:  Glenn Dranoff, MD - Dana-Farber Cancer Institute Immune Modulation by Antibody Lieping Chen, MD, PhD - Johns Hopkins University School of Medicine Immunomodulation with Antibodies Blocking the B7-H1/PD-1 Axis Suzanne L. Topalian, MD - Johns Hopkins University School of Medicine
1:00 pm - 2:30 pm	Session 3: Investigating Antibodies as "Vaccines" Chair:  Ira Mellman, PhD - Genentech, Inc. Antibody Therapeutics in Cancer: Converting Passive to Active Raphael Clynes, MD, PhD - Colubmia University Antibody-Targeted Vaccines Tibor Keler, PhD - Celldex Therapeutics, Inc.
3:00 pm - 5:00 pm	Session 4: Antibody Engineering Chair:  George J. Weiner, MD - University of Iowa Two-in-One Antibody: From Proof-of-Concept to Therapeutic Candidate Germaine Fuh - Genentech, Inc. Engineered Anti-Cancer Antibodies with Enhanced Effector Functions Pablo Umaña, PhD - Roche Glycart AG T Cell-Engaging Antibodies for Cancer Therapy Patrick A. Baeuerle, PhD - Micromet, Inc.
Saturday, October 2 - Monday, October 4, 2010
iSBTc 25th Annual Meeting For more information, please click here.

  
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.